![Nicole Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole Jones
Contatto Relazioni con gli Investitori presso
ACHIEVE LIFE SCIENCES, INC.
Profilo
Nicole Jones is currently VP-Strategic Communications & IR Contact at Achieve Life Sciences, Inc. since 2025.
Formerly, Ms. Jones worked as an Analyst at Flyover Capital Partners LLC.
Ms. Jones completed undergraduate and graduate degrees at the University of Kansas.
Posizioni attive di Nicole Jones
| Società | Posizione | Inizio |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Contatto Relazioni con gli Investitori | 01/08/2025 |
Precedenti posizioni note di Nicole Jones
| Società | Posizione | Fine |
|---|---|---|
Flyover Capital Partners LLC
 Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Analista di Private Equity | - |
Formazione di Nicole Jones
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
22
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flyover Capital Partners LLC
Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Finance |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
